NCT04349852 Verbal Working Memory and Attention Remediation for Adults With Traumatic Brain Injury.
| NCT ID | NCT04349852 |
| Status | Recruiting |
| Phase | — |
| Sponsor | NYU Langone Health |
| Condition | Traumatic Brain Injury |
| Study Type | INTERVENTIONAL |
| Enrollment | 150 participants |
| Start Date | 2021-08-01 |
| Primary Completion | 2027-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 150 participants in total. It began in 2021-08-01 with a primary completion date of 2027-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This project will examine if computerized cognitive remediation will improve working memory and attention in 25 adults with a mild, moderate, or severe brain injury and compare their cognitive performance to the control group of 25 adults with a mild, moderate, or severe brain injury. The control group will train on computerized Brain Games. Participants in both groups will be assessed prior to training and immediately post-training and one month-post training.
Eligibility Criteria
Inclusion Criteria: * Medically documented mild, moderate, or severe TBI; * All subjects will be older than 18 years of age; * Free from schizophrenia or bipolar disorder, due to the potential influence of such disorders on cognitive functioning; * Free of current alcohol or drug abuse; * At least 12 months post-injury. Exclusion Criteria: * Younger than 18 years old. * A brain injury that is not medically documented. * Being diagnosed with schizophrenia or bipolar disorder. * Current alcohol or drug use diagnosis * Less than 3 months post-injury
Contact & Investigator
Gerald Voelbel, PhD
PRINCIPAL INVESTIGATOR
NYU Langone Health
Frequently Asked Questions
Who can join the NCT04349852 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Traumatic Brain Injury. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04349852 currently recruiting?
Yes, NCT04349852 is actively recruiting participants. Contact the research team at gv23@nyu.edu for enrollment information.
Where is the NCT04349852 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT04349852 clinical trial?
NCT04349852 is sponsored by NYU Langone Health. The principal investigator is Gerald Voelbel, PhD at NYU Langone Health. The trial plans to enroll 150 participants.